- Cancer Biology
- Chromatography & Mass Spectrometry
- Contract Research
- Drug Discovery
- Drug Targets
- Flow Cytometry
- Informatics & Lab Automation
- Ingredients, Excipients and Dosages
- Microbiology & Rapid Micro Methods (RMMs)
- Process Analytical Technology (PAT) & Quality by Design (QbD)
- Raman Spectroscopy
- Screening, Assays & High-Content Analysis
- Thermal Processing
- Latest News
- About us
- Contact us
The latest news from the pharmaceutical industry and suppliers. If you have a piece of news that you would like us to cover, please contact Caroline Richards on +44 (0)1959 563311 or email us.
Probiodrug raises €22.5 million in successful Initial Public Offering and listing on Euronext Amsterdam
Posted on: 24 October 2014 | Source: Probiodrug
Probiodrug AG announces the successful completion of its Initial Public Offering, which was launched on 10 October 2014 (the “IPO” or the “Offering”)...
Trial reported in Headache and Pain journal further confirms the effectiveness of electroCore’s non-invasive vagus nerve stimulation treatment for headache
Posted on: 24 October 2014 | Source: electroCore
Preliminary results of an open-label trial carried in the journal of Headache and Pain reported that a single treatment with electroCore’s hand held non-invasive vagus nerve stimulation (nVNS) device gammaCore, completely resolved 44.8% of migraines within 30 minutes...
Posted on: 24 October 2014 | Source: European Medicines Agency
Rapid scientific advice to speed up development...
Posted on: 24 October 2014 | Source: GlaxoSmithKline
GSK announces Q3 core EPS of 27.9p +5% CER excluding divestments and dividend of 19 pence per share...
Posted on: 24 October 2014 | Source: GlobalData
The recent termination of AbbVie’s deal to acquire Shire makes this pharmaceuticals’ first major casualty of new US tax inversion legislation, and has jolted the industry out of its reverie, according to an analyst with research and consulting firm GlobalData...
Data presented at the International Society of Paediatric Oncology (SIOP) Congress show Palonosetron is a valuable option for treating pediatric patients receiving moderately to highly emetogenic chemotherapy
Posted on: 24 October 2014 | Source: Helsinn Group
Helsinn Group, the company focused on building quality cancer care, present data at the International Society of Paediatric Oncology (SIOP) congress establishing that palonosetron, at a dose 20 μg/kg, is a valuable and efficacious treatment option for chemotherapy-induced nausea and vomiting (CINV) in pediatric patients up to 17 years of age...
Posted on: 23 October 2014 | Source: MRC Press Office
The Chancellor of the Exchequer, George Osborne, has announced that a partnership led by the Medical Research Council will invest over £230 million in a range of revolutionary technologies aimed at identifying the causes of diseases such as cancer and dementia, and dramatically speeding up diagnosis and treatment...
Posted on: 23 October 2014 | Source: Cardio3 BioSciences
Cardio3 BioSciences announces the appointment of Dr. Warren Sherman as Chief Medical Officer, effective as of 1 November 2014...
Masters Speciality Pharma signs exclusivity agreement with Speciality European Pharma for the exclusive distribution of Mitocin®/Mitem® 20mg (mitomycin)
Posted on: 23 October 2014 | Source: Masters Speciality Pharma
Masters Speciality Pharma is pleased to announce a partnership agreement with Speciality European Pharma for the exclusive distribution of Mitocin®/Mitem® (mitomycin) to the Caribbean, Egypt, Kuwait, Iran, Saudi Arabia, UAE, Kenya, Seychelles, Uganda, Zimbabwe, Chile, Denmark, Greece, Ireland, Norway and Sweden...
Posted on: 23 October 2014 | Source: Santen
Santen GmbH. announced the positive outcome of the Decentralized Procedure (DCP) for TAPTIQOM® in Europe...
Posted on: 23 October 2014 | Source: Frost & Sullivan
Strong relationships with end users and an effective post sales service strategy must be a priority for wound care companies, says Frost & Sullivan...
Posted on: 22 October 2014 | Source: Distributed by APO (African Press Organization) on behalf of Rotary International
With a 90 percent reduction in polio cases, Nigeria is close to ending transmission of the poliovirus...